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Background: Historically, goal-directed fluid therapy (GDFT) has been shown to improve
patient outcomes when used in the perioperative setting for specific cases (colorectal, etc). When
anesthesia providers use GDFT protocols, intraoperative fluid therapy is” patient specific” via
the use of dynamic patient-specific physiologic parameters.
Objectives: The aim of the study is to assess whether GDFT improved patient-specific fluid
administration. A secondary aim was to assess adherence to the instated GDFT protocol.
Method: A retrospective chart review was conducted on 201 patients undergoing total hip
arthroplasty (THA) procedures following implementation of a GDFT protocol at the University
of Illinois at Chicago Hospital.
Results: The compliant group consisted of older, heavier, sicker (higher ASA score) patients
whom had more EBL during surgery. The compliant group showed a moderate-strong positive
correlation between fluid output and fluid administration (r=0.664), while the group that did not
utilize the EV-1000™ monitor and GDFT protocol had a weaker linear relationship (r=0.373).
When the protocol was used, practitioners were compliant in over 50 percent of cases for over 70
percent of the surgical time.
Conclusion: Trends suggest improved patient-specific precision of fluid administration when a
GDFT protocol is used. Further evaluations of a GDFT for THA procedures should be conducted
for increased protocol validity.
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Background
Anesthesia providers administer intravenous fluid replacement during the perioperative
period. Fluid replacement can include crystalloid, colloid, or blood products for patient
maintenance, dehydration, and intraoperative fluid loss. Literature suggests that both inadequate
and excessive fluid administration can have negative impacts on patient outcomes (Peng, Li,
Cheng, & Ji, 2014, Horosz, Nawrocka, & Malec-Milewska, 2016). Too much fluid can result in
tissue edema and organ dysfunction, while not enough fluid can result in poor organ perfusion
and organ injury. Other negative outcomes include: increased length of hospital stay, postoperative ileus, metabolic derangements, organ dysfunction, and cardiovascular compromise.
Horosz, Nawrocka, and Malec-Milewska (2016) state that excessive crystalloid administration
can result in tissue edema, hindering intestinal anastomoses and delaying return of intestinal
motor functions (possibly leading to prolonged paralytic ileus). By eliminating preoperative
bowel preparations the patient’s preoperative fluid and electrolyte status is assumed to be
normal, thus decreasing the need for high-volume intraoperative fluid replacement.
Traditionally, fluid management approaches have utilized formulas and fixed-volume
methods to maintain euvolemia in the intraoperative period. These methods include weightbased calculations assessing basal requirements as well as preoperative fluid deficits.
Intraoperatively, anesthesia providers analyze static and dynamic indicators such as mean arterial
pressure, heart rate, central venous pressure, urine output, actual/estimated blood loss, and
arterial blood gases to guide fluid replacement administration (Trinooson & Gold, 2013). The
previously described decision-making process for fluid administration has led to wide spread
differences in intraoperative fluid therapy from provider-to-provider. Recent goals for
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directed therapy is optimization of cardiac output and end organ tissue oxygen delivery while
preventing both fluid overload and under resuscitation (Warnakulasuriya, Davies, Wilson, &
Yates, 2016).
Newer innovations for measurement of patient fluid status have helped provide quantitative
indicators for fluid administration. For example, volume status indicators such as stroke volume
variation and cardiac index or cardiac output used to only be available via invasive monitors
such as pulmonary artery catheters. These invasive monitors’ benefits often did not outweigh the
risk of placement and thus, were not routinely used. As new technology has become available it
is possible to monitor such values with non-invasive monitors for routine surgical procedures.
Non-invasive monitors include esophageal doppler and plethysmographic variability index
(measured via pulse-oxymetry).
In 1995, Danish surgeon, Henrik Kehlet published controversial thoughts surrounding
perioperative care that encompass unbalanced fluid administration. Those thoughts served as a
stepping stone for the enhanced recovery after surgery (ERAS) protocols that are seen in practice
today (Horosz, Nawrocka, & Malec-Milewska, 2016).
ERAS recommendations include the following:
Preoperative preparation and counseling, curtailed fasting, avoidance of preoperative
bowel preparation, preoperative supply of carbohydrate-rich drinks, the avoidance of
pharmacological premedication, thromboembolism prophylaxis, antibiotic prophylaxis,
epidural anaesthesia, intraoperative use of short-acting anaesthetics and opioids,
restricted parenteral supply of sodium and fluids, prevention of hypothermia, prevention
of postoperative nausea and vomiting (PONV), pain management based on non-opioid
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drugs, early enteral nutrition, stimulation of GI motor activity, limited use of naso-gastric
tubes, preferences for laparoscopy (with short transverse incisions), avoidance of postoperative drains when possible, early mobilization, early removal of urinary catheters,

and evaluations of the implemented protocol and treatment outcomes (Horosz, Nawrocka,
& Malec-Milewska, 2016, p. 49-50).
ERAS protocols call for physiologically-guided intraoperative fluid replacement due to
the multitude of complications associated with under- or over-hydration. The current research
study aims to evaluate the compliance and utility of a GDFT protocol at UIC hospital. Evaluation
of the GDFT protocol includes compliance with the protocol as well as measuring variability in
fluid administration.
Problem Statement
The wide variation of fluid administration among providers, as well as the potential for
detrimental patient outcomes necessitates an inquiry into fluid administration protocols. Recent
implementation of GDFT protocol for use in a selected patient population e.g. total hip
arthroplasties at University of Illinois at Chicago hospital will be analyzed for clinical
compliance and impact on fluid administration.
Purpose Statement
The purpose of this study is to examine the implementation of a GDFT protocol in the
intraoperative period for total hip arthroplasties utilizing retrospective analysis of electronic
medical records.
Clinical Questions
In the 24 months following the implementation of a goal directed therapy protocol,
1. Does use of a GDFT protocol result in less fluid administration?
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2. Does use of a GDFT protocol reduce variability in net fluid administration (i.e.
Improve precision)?
3. What is the percentage of time that providers are compliant with the GDFT protocol
when the EV-1000™ monitor is used?
Conceptual Framework
This study is guided by two conceptual frameworks. The first, Quality Assurance Model
Using Research (QAMUR), is a continuation of the conceptual framework utilized during the
conception of University of Illinois’ GDFT protocol (Watson, Bulechek, & McCloskey, 1987).
Following identification of a problem and review of the literature, this model is then used for
either research utilization or research conduction. Original research was utilized to create a
GDFT protocol and this follow-up study will conduct new research to examine the effect of
protocol implementation.
The second conceptual framework used is the Consolidated Framework for
Implementation Research (CFIR) (Breimaier, Heckermann, Halfens, & Lohrmann, 2015). The
CFIR uses five domains (intervention characteristics, outer setting, inner setting, characteristics
of individuals, and process) to explain why an implementation may or may not succeed
(Breimaier, Heckermann, Halfens, & Lohrmann, 2015). This second theory is useful for
exploration of anesthetists’ actions that did not seem to be driven by patient-specific data or
protocol doctrine.
Literature Review
Search Method
A computerized databases search was conducted for this literature review using the
various combinations of key terms: “fluid administration”, “goal directed therapy”, “enhanced
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Complete, PubMed and CINAHL databases search yields were reviewed and the most recent
research articles were selected for review. Fourteen articles were found to be highly relevant to
the proposed study and are included in this literature review.
Current Views on Goal-Directed Fluid Therapy
Goal-directed fluid therapy (GDFT) is an individualized approach to perioperative fluid
administration using a variety of monitoring devices and dynamic variables including the
corrected flow time (FTc) and stroke volume (SV), which are objectively provided by a cardiac
output monitoring device (Miller, Roche, & Mythen, 2015). In the past decade, multiple studies
have examined GDFT versus traditional intraoperative fluid administration. Recent published
studies have also described various dynamic fluid status markers such as stroke volume variation
(SVV), pulse pressure variation (PVV) and systolic pressure variation (SPV) as reliable
indicators of “fluid responsive physiology” and therefore triggers for intraoperative fluid
administration (Gallagher & Vacchiano, 2014; Miller, Roche, & Mythen, 2015). GDFT uses the
principle of SV optimization through the use of SVV data. SVV and SV data are objective
parameters available to anesthesia providers when using a cardiac output monitor; used to tailor
fluid therapy to individual patients (Miller, Roche, & Mythen, 2015). Response to SVV is based
on the principle that cardiac output operates under the Frank-Starling law (Miller, Roche &
Mythen, 2015). Frank-Starling and colleagues demonstrated that an increase in ventricular filling
results in an increased pressure, and thus and increased force of cardiac output, or stroke volume
(SV) (Solaro, 2007). SVV is a dynamic indicator that indirectly gives information about the
filling pressure of the heart. An increase in SVV is indicative of low filling pressures, thus GDFT
protocols call for administration of fluid.
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SVV is considered a “dynamic” indicator of fluid status since data is acquired constantly,
as opposed to “static” traditional indicators such as heart rate (HR), mean arterial pressure
(MAP), and central venous pressure (CVP) that are collected only at discrete time points. These
indicators do not necessarily reflect an individual’s fluid status. HR, MAP, and CVP can be
increased or decreased due to a variety of reasons such as pain or patient positioning (Miller,
Roche, & Mythen, 2015). The goal of using SVV to direct fluid administration is to reduce
confounding factors such as pain or patient positioning.
Another commonly used indicator guiding intraoperative fluid therapy is urine output
(UO). As urine output declines, providers often increase the rate and volume of infusing fluids.
Norberg et al. (2005) conducted an animal study that demonstrated a lack of correlation between
urine output and fluid administration. In this study, sheep were divided into three groups: 1)
infusion of crystalloid solution only 2) hemorrhage only, and 3) hemorrhage plus infusion.
Results demonstrated that in the sheep that were hemorrhaged and received an infusion, there
was pronounced oliguria regardless of fluid infusion (Norberg et al., 2005). Increased
administration of fluid in the presence of oliguria resulted in fluid retention and expansion of the
tissue compartment (Norberg et al., 2005). The results of this study translate into the
intraoperative environment, as many anesthesia providers continue to bolus fluids based on
decreased urine output. Norberg et al.’s study highlights the lack of correlation between urine
output and volume status post fluid administration. Fluid administration based on urine output
has the potential for over resuscitation.
GDFT Protocol in Orthopedic Surgeries
A randomized control group trial by Peng, Li, Cheng, and Ji (2014) compared goaldirected fluid therapy to a control group of subjects undergoing orthopedic surgery. The GDFT
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group received fluid based on individualized SVV as opposed to the control group (no GDFT
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protocol) that received fluid administration based on traditional indicators such as HR, MAP, and
CVP. SVV is a reflection of a patient’s individual cardiac performance. Indicators such as MAP,
and CVP are numbers that may be ideal for one patient, but at the same value, may provide
inadequate organ perfusion in another patient. Researchers collected data regarding the variables
mentioned above, as well as time to passage of flatus post-operatively, and volume of fluid
administered (Peng et al., 2014). The results of the study revealed that the GDT group had fewer
hypotensive episodes, shorter postoperative time to flatus, and received lower volumes of
intraoperative fluid (1,850ml compared to 2,225ml) (Peng et al., 2014).
Benes et al. (2015) also compared a GDFT group to a control group (no GDFT protocol)
in patients who underwent total knee arthroplasty or total hip arthroplasty. The GDFT protocol in
this study was based off of pulse pressure variation (PPV). PPV is a measure that is then used to
calculate SVV. Fluid was administered to keep the PPV lower than thirteen percent. Benes et al.
(2015) found that subjects in the control group received significantly higher amounts of fluid and
had a higher incidence of postoperative complications such as ileus, respiratory compromise and
postoperative infection. Subjects in the control group also had a longer length of hospital stay
compared to the GDFT group.
GDFT Protocol in High-Risk Surgeries
Increased intraoperative fluid administration is implicated in several postoperative
complications, such as delayed wound healing and wound infections. A randomized controlled
trial by Scheeren, Wiesnack, Gerlach, and Marx (2013) demonstrated that postoperative wound
infection was significantly lower in a GDFT group versus the control group when undergoing
high-risk surgeries (defined based on patient specific criteria such as comorbidities and urgency
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of surgery). This study does include potential confounding factors, such as increased transfusion
of blood products in the control group. This may induce immunosuppression and predispose the
subjects to poor wound healing, however the rate of wound infections in the GDFT group
compared to the control was significant, with zero rate in GDFT group versus seven wound
infections in the control group (Scheeren, et al., 2013).
Negative Patient Outcomes Averted by GDFT Protocols
Miller, Roche, and Mythen (2015) have identified key patient outcomes for GDFT
protocols, which include reduced length of hospital stay, reduced incidence of postoperative
complications such as wound infections, and reduced mortality 180 days post-surgery. Horosz,
Nawrocka, and Malec-Milewska (2016) reiterate the fact that intra-operative over-hydration is
detrimental to the patient. Patients who received less than 2,000 milliliters (mls) in the
intraoperative period had a decreased length of hospital stay by an average of three days. The
authors also cited that treatment of hypotension with vasopressors as opposed to a fluid bolus
reduced the number of postoperative complications by 22% in the Enhanced Recovery After
Surgery (ERAS) protocol group (Horosz, Nawrocka, & Malec-Milewska, 2016). This is
important to note because intraoperative hypotension is often treated with a fluid challenge first,

administering 100-500mls of crystalloid over a short period of time. If the patient is hypotensive
due to hypovolemia, the hypotension will resolve with fluid administration. These fluid
challenges can drastically increase the total amount of intraoperative fluid the patient receives.
Miller, Roche, and Mythen (2014) state that even a modestly positive postoperative fluid
balance can be detrimental. A weight gain of 3kg (6.6 lbs) after elective colonic resection has
been shown to be associated with delayed recovery of gastrointestinal function, increased
complication rate, and extended length of hospital stay. The authors introduce the term “zero
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balance therapy” and propose that be the terminology used in this patient population. Miller,
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Roche, & Mythen (2014) also discuss the implementation of goal-directed therapy in ERAS
patients that resulted in an increase in fluid administration when compared to zero balance
therapy. This is probably attributed to the lack of preoperative hypovolemia traditionally
experienced due to bowel preps and long NPO times. Finally, the authors also touched upon the
fact that traditional markers used to guide fluid therapy intraoperatively (such as heart rate and
mean arterial blood pressure) are not always reliable indicators of blood volume (Miller, Roche,
& Mythen, 2014).
Not all studies reported decreased intraoperative fluid administration due to GDFT
protocols. Phan, An, D’Souza, Rattray, Johnston, and Cowie (2014) conducted a randomized,
prospective blind study to compare patient outcomes between GDFT ERAS protocol group
versus traditional fluid restriction group. Pahn et al. (2014) study resulted in the GDFT protocol
group receiving more boluses and an overall higher volume of intraoperative colloid
administration compared to the fluid restriction group. However, no differences in patient
outcomes in terms of length of hospital stay and post-surgical complications were seen (Phan et
al., 2014).
Trinooson and Gold (2013) performed a literature review of studies that compared GDFT
protocols with control groups in high risk surgical procedures where fluid administration was at
the discretion of the anesthesia provider. Conclusions from that literature review included an
overall increase in fluid administration as opposed to decreased fluid administration. However, a
decrease in the number of postoperative complications (7 studies out of 12), and decreased
length of hospital time (7 studies out of 12) in the GDFT group were reported (Trinooson &
Gold, 2013).
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In summary, a few studies found no significant difference between GDFT protocols and
GDFT protocol groups in key patient outcomes, but the majority of studies that utilized GDFT

protocols resulted in improved postoperative key patient outcomes, as seen in Table 1. In studies
that used GDFT protocols, it is important to evaluate the data based on compliance with the
GDFT protocol as a low compliance rate could skew outcomes against GDFT when, in fact, in
the compliant group outcome may be better.
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Table 1. Evidence-Based Table on Goal-directed Fluid Therapy
Author and Year

Study Objectives

Methods
(Design,
Sample Size,
Setting,
Human
Subjects
Issues)

Study Variables or
Constructs Measured or
Variables Controlled for
by Researchers

Instrument/s
Used to
Measure the
Construct/s

Statistics Used
for Data
Analysis

Study Findings

Conclusion

Phan, An, D’Souza,
Rattray, Johnston,
and Cowie, 2014

Comparison of fluid
restriction vs.
oesophageal Dopplerguided goal-directed
therapy (GDT) in elective
major colorectal surgery
(ERAS program)

Prospective
blinded study,
n=100, multicentre setting
in Fitzroy,
Victoria,
Australia,
study had
institutional
ethics
approval,
patients
consented to
participate

Fluid volume, type of fluid
(fluid restriction protocol
versus goal-directed
protocol), primary
outcome: length of stay
(LOS), secondary
outcomes: complication
rate, change in
hemodynamic variables
and fluid volumes

Variables
mentioned in
previous column
were obtained
via patient’s
chart

Primary
outcomes=
power analysis,
secondary
outcomes:
continuous
data= t-test,
non-parametric
data= MannWhitney U test,
hemodynamic
parameters=
paired t-test,
dichotomous
data= chisquare statistics

-GDT group had
higher volume
of
intraoperative
colloid
(P=0.012).
-Primary
outcome of LOS
was similar
between groups:
restrictive
median=6 &
GDT median=6.5
(P=0.421).
-There was no
statistical
significance
between groups
in regards to
secondary
outcome of
complications.
-There were
more MAJOR
complications in
the restrictive
group than GDT
group (nine vs.
one, P=0.007).

-GDT group received
more boluses and an
overall larger volume
of fluid in the perioperative period than
the restrictive group.
-GDT did not confer
any significant clinical
advantage within an
ERAS pathway.
-There was no
difference in LOS, or
minor or major
complications
between the two
groups.
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Pavlovic, Diaper,
Ellenberger, Frei,
Bendjelid,
Bonhomme, and
Licker, 2016

Outcomes following
emergency surgery
between two different
goal-directed therapy
(GDT) groups .
1. Control group going off
of standard fluid status
indicators
2. Optimized group using
data from PiCCOplus
monitor (CI, GEDVL,
EVLWL)

Prospective
randomized
trial, n=43,
conducted in a
single
academic
centre in
Helsinki, ethics
approval,
consent by
patient and/or
family

Fluid volume and type
administered,
administration of
inotropes, variables
driving fluid
administration/inotrope
use: control group= PPV
and conventional targets
(MAP, HR, UO, Hb, lactate)
intervention group= CI,
GEDVI, EVLWI.
Primary outcomes=
intraoperative change in
arterial blood lactate and
short-term organ
dysfunction. Secondary
outcomes= Hospital and
ICU LOS, and composite
morbidity index ranking.

Data points
gathered
retrospectively
from patient
chart.

Mann-Whitney
or student t
tests were used
for continuous
data and
Fisher’s exact
tests for
categorical
data.

-There was no
difference in
intraoperative
fluids
administered
between the two
groups.
-Dobutamine
was used in 9
out of 20
patients in
optimized
group, while
none in the
control group
received
dobutamine.
-Blood lactate
levels changed
little in the two
groups (-0.2+/1.2mm/l in
control group
and -1.2 +/1.4mm/l in
optimized
group, p=0.078).
-ICU and
hospital LOS did
not differ
significantly
between groups.
-Mortality= 13%
in control group
and 25% in
optimized group
was actually
much less than
predicted by
morbidity index
ranking (60+/20 in control
and 62+/- in
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-In high risk
emergency patients,
GDT utilizing PiCCOderived parameters
led to increased use of
intraoperative
inotropes that were
associated with less
favorable outcomes
-The trial was
interrupted due to
interim analysis on
efficacy and safety.
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Scheeren,
Wiesenack, Gerlach,
and Marx, 2013

Randomized trial of highrisk surgical patients
assigned to control group
or goal-directed therapy
(GDT) group. GDT was
based on continuously
monitored stroke volume
variation (SVV) and
stroke volume (SV).
Control group had no
practice changes.

Prospective
randomized
multicentre
study, n=64,
ethical
approval from
ethics
committee of
University
Hospitals,
Rostock,
Germany.
Patients gave
informed
consent prior
to
participation.

Hemodynamic parameters
that were collected: heart
rate (HR), mean arterial
pressure (MAP), arterial
oxygen saturation by pulse
oximetry (SpO2), central
venous pressure (CVP),
stroke volume variation
(SVV), and stroke volume
(SV). Data from the flotrac
system (SVV and SV) were
made available to the GDT
group but was hidden from
the control group.
A protocol for fluid therapy
based on SVV and SV was
then followed in the GDT
group.
Primary outcomes=
number of complications
(infectious, cardiac,
respiratory, renal,
hematologic and
abdominal), SOFA score
(organ dysfunction)

Data was
gathered via
chart review and
entered into
statistical
software.

Number of
complications
developed post
surgery,
maximum SOFA
score,
comparison
performed
either by using
t-test or MannWhitney test (if
data deviated
from normal
distribution.

optimized
group).
-Optimized
group had more
major
complications
(95%) versus
the control
group (40%),
P<0.001.
-During surgery,
both groups
received similar
amounts of
fluids (P=0.86).
- HR, MAP, CVP,
SV and SVV
were
comparable
between groups.
-SVV decreased
in the GDT
group (from 9.1
to 8.0%,
P=0.048) but
not in the
control group
(8.9 to 8.8%).
-Time that SVV
<10% was
greater in the
GDT group
versus the
control
(P=0.41).
-Post-operative
wound
infections was
significantly
lower in the
GDT group (0 vs.
7, P=0.01).
-The number of
post-operative
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-Fluid management
based on SVV and SV
optimization
decreases postoperative wound
infections.
-Larger follow-up
studies are needed but
findings suggest that
goal-directed strategy
might decrease postoperative organ
dysfunction.
-Higher volume of
blood transfusions in
the control group and
resulting
immunosuppression
may contribute to
decreased wound
healing.
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Fischer, et al., 2016

Comparison of postoperative colorectal
surgical patients using
photoplethysmography
and perioperative
hemodynamic
optimization algorithm
versus a control group
(data from EV1000
monitor unavailable).
Outcomes being examined
are post-operative
complications.

Norberg, et al., 2005

Assessing fluid shifts in
three groups of sheep: A.
Infusion only B.
Hemorrhage only and C.
Hemorrhage plus
infusion.

Randomized,
controlled,
two-arm trial,
n=160,
randomized
via scratch
card that is
generated
using
permutated
blocks, IRB
approval
obtained from
University
Hospital of
Caen in
France,
consent
obtained from
participants
Randomized
trial using
animal
subjects, n=12
(4 per group),
approval
obtained from

Control group variable=
mean arterial pressure
(MAP),
photoplethysmography
group variable= stroke
volume (SV) and MAP.
Primary
outcome=incidence of
postoperative complication
during 30 days following
surgery.
Secondary outcomes= total
number of postoperative
complications, length of
hospital says, and
postoperative mortality.

Data collected
by blinded third
party.

Primary
outcome
comparison
performed by
Fisher exact or
Pearson chisquare test.

Variables include: cardiac
output (CO), mean arterial
pressure (MAP),
transcapillary flow, plasma
volume, and urine output.

Data was
gathered in real
time during the
experiment.

Comparison of
transcapillary
flow amongst
the three
groups was
done using the
Wilcoxon

complications
per patient and
maximum SOFA
score was all
lower in the
GDT group,
although not
statistically
significant.
-The control
group tended to
receive more
red blood cells
than the GDT
(685 vs. 319 ml,
P=0.063).
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Study is taking
place from
December 2014
tentatively until
December 2016.

Limitations of study
include: population
being limited to
colorectal surgery
patients, study
population is of
intermediate risk (not
high-risk).

- No significant
difference in CO
was noted
between the
three groups.
-MAP was
transiently

-Hemorrhage caused
an inhibition of renal
output.
-There was a marked
impairment of diuresis
after hemorrhage that
caused an
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the
Institutional
Animal Care
and Use
Committee of
the University
of Texan
Medical
Branch,
Galveston, TX.

Benes, Zatloukal,
Simanova, Chytra,
and Kasal, 2014

Evaluation of costeffectiveness of goaldirected therapy (GDT)
implementation.

Direct
comparison
between study
groups and
control groups
originally in a
randomized
study, n=120
(60 per
group),
approval from
ethics
committee at
Charles
University in
Czech Republic
was received
and informed
consent from
participants
was obtained.

Variables assessed
included: postoperative
complications (further
divided into
subcategories),
hospitalization costs,
patient care costs, clinical
examinations/procedure
costs, biochemistry,
antimicrobials, radiology
diagnostics, and other.

Data was
retrospectively
collected from
patients whom
participated in a
previous GDT
study.

signed ranks
test.
Interventions
were assessed
at the 0.05 level
of significance.

decreased in
group B and
increased in
group A, group C
had higher MAP
than
hemorrhage
alone (B).
-Cumulative
urinary output
was 924+/-371
(group A),
255+/- 135ml
(group B), and
537 +/- 233ml
(group C).

Mann-Whitney
and KruskalWallis tests
were used to
assess the
difference
between study
groups.

-The occurrence
of any
complication,
regardless of
allocation,
increased the
costs of
postoperative
care by 2295+/3611 Euros.
-The overall
costs of care
tended to be
lower for GDT
versus control
(p=0.596),
although not
statistically
significant.
-GDT
intervention
reduced the
number of
complications
(34 vs. 78;
p=0.007).
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accumulation of
infused crystalloids
outside the vascular
space. This supports
the theory that
difficulty of
determining optimal
blood volume
substitution during
surgery and
hemorrhage and
supports the
suggestion that
overhydration might
be a common feature,
especially if urinary
output is used as a
monitor of hydration.
-The mean cost per
patient in the GDT
group was lower than
the control
-Overall, the incidence
of postoperative
complications was
lower for the GDT
group compared to the
control.
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Benes, et al, 2015.

Assessment of
postoperative morbidity
when using goal-directed
therapy (GDT) versus
control group in two
patient surgical
categories: total knee
arthroplasty and total hip
arthroplasty.

Trinooson and Gold,
2013

Literature review of RCTs
measuring the impact of
perioperative goaldirected therapy (GDT)
on outcomes among
patients undergoing highrisk surgical procedures

Warnakulasuriya,
Davies, Wilson, and
Yates, 2016

Examining a difference in
fluid administration when
using Pleth Variability
Index (PVI) compared to
esophageal Doppler in
low risk patients
undergoing major
colorectal surgery.

Randomized,
two-stage
study, n=120
(40 per group:
control, GDT,
and
restrictive),
IRB approval
received from
Charles
University
Hospital in
Czech
Republic, all
patients gave
informed
consent.

12 randomized
controlled
human trials
were included;
results further
narrowed by
only including
patients inside
the
perioperative
arena, all
studies
represented
level 2
evidence.
Randomized
controlled
trial, n=34,
ethics
approval
granted by
NRES
CommitteeYorkshire and
The HumberLeeds West,

Primary outcome= number
of patients with any
postoperative organ or
infectious complication.
Secondary outcomes=
hospital length of stay and
all-cause mortality.

Blinded
investigators
evaluated
patient data.

Variables included volume
(pulse variation, stroke
volume, stroke volume
variation), flow (cardiac
output, cardiac index, SV),
oxygen delivery (mixed
venous saturation),
postoperative
complications and
morbidity

Literature
review
conducted by
authors

Primary outcome= total
volume of fluid
administered in the
intraoperative period.
Secondary outcomes=
differences in 24 hour fluid
balance, biochemical
markers of tissue
perfusion, morbidity at
days 1,3,5, and 7, the

Data points
collected during
trial.
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For intergroup
comparison:
one-way
ANOVA.
For timedependent
variables:
repeated
measures
ANOVA.
Categorical
variables tested
using chisquare test.
Tested at
significance
level of
p=0.005.
Varied among
studies

-Rate of
complications
was higher in
control group
when compared
to GDT group
(88% vs. 55%,
p=0.02).
-Length of
hospital stay
was increased in
control group,
likely attributed
to the higher
incidence of
complications

-Control group
patients received
significantly higher
amounts of fluid
compared to both
protocol groups.
-Overall, GDT has
decreased level of
postoperative
complications.

Common
themes noted
throughout
studies:
-Decrease in
hospital stay
among GDT
group (100%)

-More research needs
to be done, i.e. Large
multi-site trials of
various GDT protocols
are needed to further
evaluate the effects of
GDT modalities.

Statistical
significance
level= p<0.05.
Analysis of data
achieved using
independent
samples t-test,
analysis of
variance, MannWhitney U test

-There was no
significant
difference in
volume of fluid
administered
using PVI or
Doppler.
-Biomarkers did
not significantly
vary among
groups

-In low-risk patients
undergoing major
colorectal surgery
there was no
significant difference
in fluid administration,
postoperative
morbidity, or hospital
length of stay.
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conducted at
the York
Hospital,
written
informed
consent was
obtained.

presence of complications,
and length of hospital stay.

and Fisher
exact test.

Miller, Roche, and
Mythen, 2014

Literature review of
components of ERAS
protocols and
management of
perioperative fluids

Varied

Pre-intra- and postoperative fluid
management, Fluid
challenge, goal-directed
therapy, complications

Info gathered via
lit. review

Multiple

Peng, Li, Cheng, and
Ji, 2015

Evaluation of the
influence of stroke
volume variation (SVV)based goal-directed
therapy (GDT) on
splanchnic organ
functions and
postoperative
complications in patients
undergoing orthopedic
surgery.

Randomized
controlled
trial, n=80 (40
in
intervention,
40 in control
group),
approval from
Institutional
Research
Ethics
Committee,

Variables: stroke volume
variation (SVV), heart rate
(HR), mean arterial
pressure (MAP), central
venous pressure (CVP),
urine output (UO), time to
passing first flatus.
Intraoperative organ
perfusion (via arterial and
gastric intramucosal pH,
and PCO2 of gastric
intramucosa.

Chart Review

Normally
distributed data
analyzed via
paired or
unpaired ttests.
Nonnormally
distributed data
tested via
Mann-Whitney
U test and
Wilcoxon rank-

-Post-operative
complication
rate was higher
in the Doppler
group; however
they did not
reach statistical
significance.
-Median
hospital length
of stay was 7 for
both groups
(p=0.735);
-One study
(Noblett, et a.)
had a
statistically
significant
reduction in
complications
and hospital
length of stay in
the GDT group
(P=0.04, and
P=0.005
,respectively)

The mean HR in
the GDT group
was lower than
the control
(p=0.028), there
were fewer
hypotensive
episodes in GDT
group
(p=0.021),
Volume of
intraoperative
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-GDT has been shown
to decreased hospital
LOS and complications
after major surgery.
-In the absence of
other concerns,
perioperative oliguria
should be tolerated.
-Intraopertive oliguria
was not associated
with renal failure, fluid
overload results in
tissue edema which
may directly impact an
encapsulated organ
such as the kidney and
participate in the
formation of acute
kidney injury.
Main findings: SVV
based GDT reduced
required volume of
intraoperative fluids,
maintained
hemodynamic
stability, and
improved
perioperative
gastrointestinal
function.
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informed
consent
obtained from
subjects.

Hemodynamic data,
hospitalization,
postoperative
complications, and
mortality also recorded.

sum test.
Categorical data
analyzed via
Fisher’s exact
test. P<0.05
considered
statistically
significant for
each test.

fluid
administration
was lower in
GDT group
(p=0.036). Time
to first flatus
was shorter in
GDT group
(p=0.042).
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There was no
difference in urine
output,
hospitalization,
complications, or
mortality.
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Research Design
This study utilized a quantitative, retrospective study design. Utilizing a retrospective
chart review of the specific patient population (hip arthroplasties at University of Illinois at
Chicago Hospital), key concepts were used as data points. The data was analyzed for statistical
significance and correlation between fluid therapy administration versus patient output
(including urine output and estimated blood loss). Patient indicators and total fluid
administration volume were also analyzed for variance between patient ASA score or the use of
EV-1000 ™ monitoring.
Sample and Setting
This review was approved by the Institutional Review Board (IRB) at UIC and an IRB
Authorization Agreement was made between UIC and DePaul University’s IRB. Subjects of this
study included patients undergoing total hip arthroplasty (THA) at University of Illinois at
Chicago (UIC) Hospital. Case information was obtained from UIC’s electronic charting system,
Cerner SA-Anesthesia.
The sample size was 201 patients over a 23-month period, starting from implementation
of GDFT protocol in January 2016. Inclusion criteria included: male and female patients aged
28-88 years, ASA status I, II, III, surgery duration greater than 60 minutes (so as to analyze
intravenous fluid administration in milliliters per kilogram per hour). Exclusion criteria include:
ASA IV, emergency surgery, surgery duration less than 60 minutes, and vulnerable populations
(pregnant women, children).
Definitions of Key Concepts
Key concepts of this study include:
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Fluid administration. The concept of fluid administration is important, both
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conceptually and operationally. Conceptually, one must understand that fluid administration
entails replacement of vascular volume and effects patient status and outcomes. Operationally,
this study looks at fluid administration in terms of quantity and quality. Fluid quantity is
measured in milliliters. Quality of fluid is documented as type of fluid: crystalloid (lactated
ringers or normal saline) or colloid (albumin).
Length of surgery. The length of surgery puts fluid administration into context.
Generally, the longer the surgery, the more blood loss is involved and/or the need for more fluid
replacement increases.
Patient indicators. Patient indicators serve as clues as to why a type or quantity of fluid
was given, but also as an indicator for patient’s response to fluid administration. Indicators
included in this study were: estimated blood loss (mls), stroke volume variation (SVV), and urine
output (mls).
ASA status: The American Society of Anesthesiologists physical class status places
patients into classes I-VI. Classification is based on physical health with class I being a young,
healthy patient and class VI as a brain dead patient. Classes I-III include: healthy, mild, and
moderate systemic disease, respectively. Only ASA I-III were included in this study to minimize
physiologic fluid shifts, deficits, and responses to fluid administration and blood loss that may be
more profound when a patient is unhealthy.
Human Subjects Protection
Subjects of this study are protected in the following ways. Access to study data is limited
to the primary investigator, Michelle Pavlik, BSN, RN, and committee members, Randal Dull,
Ph.D, MD, and Karen Kapanke, DNP, CRNA, whom have all completed Collaborative
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Institutional Training Initiative (CITI) training. Strict adherence to Health Insurance Portability

and Accountability Act (HIPAA) is maintained. All patient information was collected and stored
using a password protected medical record database. The data analyst had access to datasets with
patient data in order to ensure validity and accuracy. A de-indentified dataset was provided for
analysis using arbitrary numbers attached to each patient. Finally, this study was approved by
institutional review boards at both UIC and DePaul University.
Data Collection
Data collection was completed with assistance from UIC Data Analyst Yash Patel. Data
was pulled from Cerner SA-Anesthesia by using their Business Objects query system. Data was
separated into the following four datasets: Descriptive, ClinicalEvents, Actions, and
MonitoredValues (see Appendix A). There was one record in the Descriptive dataset that
corresponds to each patient case. Clinical events included any drug of fluid administered. The
Actions dataset captured monitoring instruments (i.e EV-1000™). The monitored values dataset
contained blood pressure, stroke volume variation, stroke volume index, and other values
captured by the EV-1000 ™ and monitoring equipment.
Cases were grouped into two categories: compliant and non-compliant. The compliant
group consisted of cases utilizing the EV-1000™ monitor (and thus utilizing the GDFT protocol)
while the non-compliant group did not. Use of the EV-1000™ device was inferred from the
appearance of SVV values in the case record.
Objective #1: Evaluate IVF administration amongst groups. Did the EV-1000™ group
receive less fluid when compared to the non-EV-1000™ group?
Objective #2: Is there less variability i.e. more precision in net fluid administration when
the EV-1000™ is used?
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Objective #3: What is the percentage of compliance with the GDFT protocol when the
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EV-1000™ was used?
Data Analysis
Intraoperative data was analyzed using the programming language R. Frequencies,
means, and standard deviations were calculated for descriptive statistics. Means and standard
deviations were used for analysis of net fluid administration, ASA category, primary vs. re-do
THA, as well as body weight comparison amongst the EV-1000™ compliant and non-compliant
groups. A two-tailed t-test was used to analyze estimated blood loss between EV-1000™ and
non-EV-1000™ groups. A 95% confidence interval was reported with a p value of ≤0.05
considered statistically significant.
Histograms were used to display intraoperative SVV distribution and stacked bar plots
were used to analyze fluid administration per each patient (n=201). Finally, scatter plots were
used to display fluid output vs. input for compliant and non-compliant cases.
Results
A total of 225 adult total hip arthroplasty cases were obtained via Cerner Powerchart for
analysis. Thirteen cases were duplicates and seven had body weights of zero kilograms recorded
and were thus excluded from the study. Four cases were additionally excluded from the study
due to incomplete or missing data. The sample size was then split into two categories, compliant
and non-compliant based on the use or non-use of the EV-1000™ monitor.
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The study sample included 102 males and 103 females ranging in age from 28-88 years.
Ranges of additional sample descriptives are provided in Appendix A, Figure 2. There were a
total of sixty-three cases that used the EV-1000™ monitor and 138 that did not.
Use of the EV-1000™ monitor was demonstrated by evidence of monitor-specific
parameters (SVV, SVI, etc.) on the electronic anesthesia record. From cases that used the EV1000™ monitor, a time weighted mean SVV was calculated using a midpoint Riemann Sum
(Figure 3a) and a compound logical function was used to calculate percent time compliant
(Figure 3b). Percent time compliant is defined as the percentage of time that the SVV value fell
within the identified goal value of less than twelve percent, per GDT Protocol (Figure 8). Percent
SVV and percent time compliant values are represented as histograms in Figures 3a and 3b. The
mean percent SVV is left skewed, meaning the mean SVV for majority of compliant cases did
fall within the goal percentage of less than twelve percent. Figure 3b shows the histogram for
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percent time compliant which was right skewed. Over fifty percent of cases using the EV-
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1000™ monitor were compliant for seventy percent or greater of the total surgical time.
Cumulative fluid values were calculated using the formula (Lactated Ringers + Normal
Saline 0.9% + Albumin), which was then compared to cumulative EBL and urine (EBL + Urine)
on the same graph (Figures 4a, 4b, & 4c). Cumulative fluid administration varied from 5009,500mL as seen in Figure 4a. Figures 4b and 4c show cumulative fluid values for compliant and
non-compliant groups with the mean being 2,508mL and 2,410 respectively.
Net fluid administration was calculated with the formula (Cumulative Fluids –
Cumulative Output (EBL + Urine) / Patient Weight/Procedure Duration) with the resultant units
in milliliters per kilogram per minute (ml/kg/min). Net fluid administration did not vary amongst
groups with the mean = 0.11mL/kg/min (SD= 0.08) in the compliant group and 0.12mL/kg/min
(SD= 0.09) in the noncompliant group. In addition, net fluid administration values were colored
by ASA value (Figures 5b and 5c). As Figure 5b shows, patients in the compliant group
consisted of almost fifty percent ASA classification threes and ASA twos (SD= 0.50), while the
non-compliant group had significantly more ASA twos (SD= 0.46) (Figure 5c). The mean ASA
classification for the compliant group was 2.49 and 2.27 in the non-compliant group.
Mean values, standard deviations (SD), and p-values were analyzed for both the
compliant and non-compliant groups at a 95% confidence interval (CI) using a two-tailed t-test,
in the following categories: EBL, Fluids (cumulative), Net Fluid administration, ASA category,
Patient Weight and Patient Age (Figure 6). No significant correlations were found, however
trend is that the compliant group consisted of older, heavier, sicker (higher ASA score) patients
whom had more EBL during surgery (compliant EBL mean=728.65, non-compliant EBL
mean=536.34).
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Cumulative output was plotted against fluid administration for total THA cases as well as
compliant and non-compliant groups (Figures 7a, 7b, and 7c). The reference line in these graphs
represents a predicted 1:1 relationship between fluid loss and replacement, utilizing the formula
([3 x EBL] + Urine). The calculated correlation coefficient for fluid output versus input for all
THA cases was moderately positive (r=0.515). Figure 7b shows a moderate-strong positive

correlation between fluid output and fluid administration in the compliant group (r=0.664), while
the group that did not utilize the EV-1000™ monitor and GDFT protocol (Figure 7c) had a
weaker linear relationship (r=0.373). The data points for cases on figures 7a, 7b, and 7c are also
color coded according to a formula calculating patient weight multiplied by surgical duration (kg
x min). Data points plotted in blue have a lower weight x duration score and the data points
progress in color to an orange color as the weight x duration score increases.
Discussion
This single-center study evaluated the implementation and compliance with a goaldirected fluid therapy protocol for THA procedures during a two-year period. Overall, there was
low implementation of the GDFT protocol, with 69 percent of THA cases being non-compliant
with use of the EV-1000™ monitor. Such low overall protocol implementation may be attributed
to the fact that the facility only owns a couple of EV-1000™ monitors which may have already
been in use when some THA procedures started. When the monitor was used, providers followed
the protocol correctly as evidenced by the high percentage of time compliant.
The results of this retrospective chart review showed a higher amount of fluid
administration when the GDFT protocol was used; the opposite of researchers’ hypothesis of less
overall fluid administration in the GDFT group. However, a higher EBL and higher ASA score
was noted in the GDFT protocol-compliant group. Follow-up studies should include randomized
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groups to avoid this issue. It can be hypothesized that anesthesia providers were more likely to
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use the EV-1000™ monitor for older, heavier, sicker patients or when a greater amount of EBL
was expected.
Net fluid administration did not significantly vary amongst groups, with a mean of
0.11mL/kg/min administered in the EV-1000™ compliant group and 0.12mL/kg/min in the noncompliant group. While the overall net amount of fluid administration was not decreased when
the GDFT protocol was used, there was a stronger correlation between fluid loss and
administration in the GDFT compliant group (r=0.664). The coloring of case’s weight x duration
was significant. A case with a lower weight x duration score would be predicted to receive less
fluid based on traditional replacement formulas and the more orange the data point gets the more
fluid replacement (i.e. more blue data points in quadrant III and more orange data points in
quadrant I). This predicted pattern is observed in the non- EV-1000™ group where traditional
IVF replacement calculations are used (Figure 7c) but there is no obvious pattern of distribution
in the compliant group (Figure 7b). This leads researchers to believe that fluid administration
precision did in fact improve, meaning the right patient got the right amount of fluid. While this
trend would be more heavily emphasized with a larger compliant group, these results are
positive. These results demonstrate the goal of a truly patient-specific GDFT intervention during
this study when the EV-1000™ monitor was used.
Limitations
Although this two-year review on implementation of a GDFT protocol showed promising
trends there were limitations. The most significant limitation being the small sample size of cases
that utilized the EV-1000™ monitor and protocol. As noted above, there may have been
provider-dependent discretions when deciding to use the monitor and protocol.
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Patient factors could not be controlled, specifically in relation to practitioner
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interventions (ie. fluid bolus). Intravenous fluid administration is often guided by patient vital
signs and controlling those variables could have provided a more accurate assessment of patientdirected fluid administration precision.
Recommendations
There are two recommendations based on this study’s findings. First, effort should be
made to increase GDFT protocol use amongst anesthesia providers during THAs at UIC. Trends
found in this study look promising and a more robust sample size would benefit further
evaluations. Re-energizing the implementation of this protocol can be achieved by anesthetist
education/reminders as well as ease of access to the protocol (i.e. placing protocol on each
anesthesia cart or in rooms where THA procedures are performed). While more costly, it may be
beneficial to increase the amount of EV-1000™ monitors available for use at the facility.
Second, further evaluation of this GDFT protocol is needed to draw strong conclusions,
especially if controlled factors can be increased in subsequent studies. With more promising
trends in relation to GDFT protocols, one can infer that it may be beneficial to expand the
protocol to other surgical specialties in the future.
Conclusion
While the volume of fluid administration did not vary significantly between the two
groups that were compared, there was a stronger correlation between patient-specific output and
input when a GDFT protocol was used. Small sample size may have contributed to decreased
study strength but the trends looked promising. Further research needs to be done to evaluate the
effect of a GDFT protocol, ideally after increased provider utilization of protocol. Follow-up
studies may look at patient outcomes such as length of hospital stay or complications amongst
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EV-1000™ and non- EV-1000™ groups. Continued studies may also look at other factors in
conjunction with GDFT protocol such as use of tranexamic acid to decrease EBL as well as
vasopressor use in relation to fluid administration. This retrospective chart review revealed
promising trends and serves to be a good guide for further protocol evaluations.
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Appendix
Figure 1

##
##

Descriptive
205

ClinicalEvents
1056939

Columns pulled by Table:
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##

Actions MonitoredValues
17722
695921

$Descriptive
[1] "Case Number"
[3] "Financial Number"
[5] "Patient Weight"
[7] "Actual Procedure"
[9] "Age- Years (Visit)"
[11] "ASA Class"
[13] "Actual Start Date and Time"
[15] "Procedure End Date and Time"

"Person Name- Full"
"Sex"
"Actual Anesthesia Type"
"Actual Surgery Duration"
"Anesthesia Duration"
"Procedure Duration"
"Procedure Start Date and Time"
"Surgical Case Specialty"

$ClinicalEvents
[1] "Case Number"
"Person Name- Full"
[3] "Financial Number"
"Clinical Event"
[5] "Clinical Event Result"
"Clinical Event Result Units"
[7] "Clinical Event End Date & Time"
$Actions
[1] "Case Number"
[3] "Financial Number"
[5] "Action Name"
$MonitoredValues
[1] "Case Number"
[3] "Financial Number"
[5] "Monitor Unit of Measure"
[7] "Monitored Value Date & Time"

"Person Name- Full"
"Action Performed Date & Time"
"Action Detail Description"
"Person Name- Full"
"Monitor Category Name"
"Monitor Name"
"Monitor Charted Value"
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SummaryDescriptiveStats[["SummaryTables"]]
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##

$Sex
FEMALE
102

MALE
103

$`Actual Anesthesia Type`
Block Epidural
2
15

General
175

Spinal
13

$`Actual Procedure`
Total Hip Arthroplasty Total Hip Arthroplasty Revision
176
29
$`ASA Class`
1
2
1 135

3
69

$`Surgical Case Specialty`
Orthopedics SN
205

SummaryDescriptiveStats[["SummaryRanges"]] %>% lapply(paste, collapse = " to
")
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##

$`Patient Weight`
[1] "36.8 to 146.2"
$`Actual Surgery Duration`
[1] "65 to 850"
$`Age- Years (Visit)`
[1] "28 to 88"
$`Anesthesia Duration`
[1] "138 to 1109"
$`Procedure Duration`
[1] "36 to 850"
$`Actual Start Date and Time`
[1] "2016-01-05 07:12:00 to 2017-12-26 09:18:00"
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